Ameliorative effect of pioglitazone on seizure responses in genetically epilepsy-susceptible EL mice

Brain Research

Volumn 1102, Issue 1, 2006, Pages 175-178

  Okada, Kazumasa ^a   Yamashita, Uki ^a   Tsuji, Sadatoshi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Cytokine; EL mouse; Epilepsy; Pioglitazone

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPILEPSY; GENE EXPRESSION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME;

ANIMALS; ANTICONVULSANTS; BRAIN; CYCLOOXYGENASE 2; CYTOKINES; EPILEPSY; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEIZURES; THIAZOLIDINEDIONES;

EID: 33746214620     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.04.108     Document Type: Article

References (28)

1. Balosso S., Ravizza T., Perego C., Peschon J., Campbell I.L., De Simoni M.G., and Vezzani A. Tumor necrosis factor-a inhibits seizures in mice via p75 receptors. Ann. Neurol. 57 (2005) 804-812
2. Breidert T., Callebert J., Heneka M.T., Landreth G., Launay J.M., and Hirsch E.C. Protective action of the peroxisome proliferators-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease. J. Neurochem. 82 (2002) 615-624
3. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B.A., and Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc. Natl. Acac. Sci. U. S. A. 90 (1993) 10061-10065
4. Crespel A., Coubes P., Rousset M.C., Brana C., Rougier A., Rondouin G., Bockaert J., Baldy-Moulinier M., and Lerner-Natoli M. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res. 952 (2002) 159-169
5. De Luca G., Di Giorgio R.M., Macaione S., Calpona P.R., Costantino S., Di Paola E.D., De Sarro A., Ciliberto G., and De Sarro G. Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice. Pharmacol. Biochem. Behav. 78 (2004) 75-81
6. De Simoni M.G., Pergo C., Ravizza T., Moneta D., Conti M., Marchesi F., De Luigi A., Garattini S., and Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 12 (2000) 2623-2633
7. Heneka M., Klockgether T., and Feinstein D.L. Peroxisome proliferators-activated receptor-γ ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J. Neurosci. 20 (2000) 6862-6867
8. Jankowsky J.L., and Patterson P.H. The role of cytokines and growth factors in seizures and their sequelae. Prog. Neurobiol. 63 (2001) 125-149
9. Kalueff A.V., Lehtimaki K.A., Ylinen A., Honkaniemi J., and Peltola J. Intranasal administration of human IL-6 increases the severity of chemically induced seizures in rats. Neurosci. Lett. 365 (2004) 106-110
10. Kelley K.A., Ho L., Winger D., Freire-Moar J., Borelli C.B., Aisen P.S., and Pasinetti G.M. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol. 155 (1999) 995-1004
11. Kersten S., Desvergne B., and Wahli W. Roles of PPARs in health and disease. Nature 4405 (2000) 421-424
12. Kielian T., and Drew P.D. Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. J. Neurosci. Res. 71 (2003) 315-325
13. Kuroda E., Sugiura T., Okada K., Zeki K., and Yamashita U. Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC. J. Immunol. 166 (2001) 1650-1658
14. Okada K., Yuhi T., Tsuji S., and Yamashita U. Cyclooxygenase-2 expression in the hippocampus of genetically epilepsy susceptible El mice was increased after seizure. Brain Res. 894 (2001) 332-335
15. Okada K., Matsunaga K., Yuhi T., Kuroda E., Yamashita U., and Tsuji S. The long-term high-frequency repetitive transcranial magnetic stimulation does not induce mRNA expression of inflammatory mediators in the rat central nervous system. Brain Res. 957 (2002) 37-41
16. Park E.J., Park S.Y., Joe E., and Jou I. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. J. Biol. Chem. 278 (2003) 14747-14752
17. Peltola J., Hurme M., Miettinen A., and Keränen T. Elevated levels of interluekin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res. 31 (1998) 129-133
18. Rong T., and Baudry M. Seizure activity results in a rapid induction of nuclear factor-κB in adult but not juvenile rat limbic structures. J. Neurochem. 67 (1996) 662-668
19. Storer P.D., Xu J., Chavis J., and Drew P.D. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. J. Neuroimmunol. 161 (2005) 113-122
20. Shandra A.A., Godlevsky L.S., Vastyanov R.S., Oleinik A.A., Konovalenko V.L., Rapoport E.N., and Korobka N.N. The role of TNF-α in amygdala kindled rats. Neurosci. Res. 42 (2002) 147-153
21. Suzuki J., and Nakamoto Y. Seizure patterns and electroencephalograms of El mouse. Electroencephalogr. Clin. Neurophysiol. 43 (1977) 299-311
22. Suzuki M., Odaka H., Suzuki N., Sugiyama Y., and Ikeda H. Effects of combined pioglitazone and metformin on diabetes and obesity in Wistar fatty rats. Clin. Exp. Pharmacol. Physiol. 29 (2002) 269-274
23. Takemiya T., Suzuki K., Sugiura H., Yasuda S., Yamagata K., Kawakami Y., and Maru E. Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins Other Lipid Mediators 71 (2003) 205-216
24. Turrin N.P., and Rivest S. Innate immune reaction in response to seizures: implication for the neuropathology associated with epilepsy. Neurobiol. Dis. 16 (2004) 321-334
25. Veech R. The therapeutic implication of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins, Leukotrienes Essent. Fatty Acids 70 (2004) 309-319
26. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., De Simoni M.G., Sperk G., Andell-Jonsson S., Lundkvist J., Iverfeldt K., and Bartfai T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acac. Sci. U. S. A. 97 (2000) 11534-11539
27. Vezzani D., Moneta C., Richichi C., Perego C., and De Simoni M.G. Functional role of inflammatory cytokines and anti-inflammatory molecules in seizures and epileptogenesis. Epilepsia 43 (2003) S30-S35
28. Yoneda Y., Ogita K., Kabutoz H., and Mori A. Selectively high expression of the transcription factor AP1 in telencephalic structure of epileptic El mice. Neurosci. Lett. 161 (1993) 161-164